The Jaundice That Changed the Family’s Timeline: Majed Al-Shehri’s Hepatocellular Carcinoma Liver Resection Story from Saudi Arabia to Turkey

Patient Profile

Name: Majed Al-Shehri

Age: 58

Condition: Hepatocellular carcinoma

Treatment: Liver resection, TACE, RFA or transplant evaluation according to stage

Destination: Istanbul, Turkey

Journey at a Glance

Main problems: Abdominal pain and distension; Jaundice (yellowing of skin/eyes); Unexplained weight loss; Fatigue and loss of appetite

Previous care: Consultation at major Saudi tertiary centers (King Majed Al-Shehri Specialist Hospital, National Guard Hospital); Imaging (CT, MRI, ultrasound) and biopsy confirmation; Discussion of chemotherapy or best supportive care

Travel driver: Access to specialized hepato-oncologic surgery, shorter treatment timeline, cost efficiency, and second-opinion validation from an internationally recognized center

Treatment explored: Liver resection, TACE, RFA or transplant evaluation according to stage

Personal goal: Secure a multidisciplinary treatment plan while he remains eligible for disease-directed therapy.

"Just take the medication and rest," your brother says over tea.

"The hospital will call when they have a date," your colleague insists.

"We just have to be patient," your spouse whispers in the dark.

Majed Al-Shehri is not a real PlacidWay patient.

He is a fictional composite built from the actual situations, medical records, and questions Saudi Arabian patients face every day.

He is fifty-eight years old and lives in Riyadh.

Before the jaundice appeared, he managed a logistics firm in the Olaya district.

He played squash on Thursday evenings.

He drove his youngest daughter to university.

He maintained the family property in the suburbs.

He explained the abdominal pain away as indigestion from late office meals.

He ignored the unexplained weight loss as a belated benefit of dietary changes.

He attributed the deep fatigue to aging and long working hours.

Then the symptoms accumulated.

The ultrasound.

The referral to King Majed Al-Shehri Specialist Hospital.

The MRI confirmation.

The needle biopsy.

Hepatocellular carcinoma, primary liver cancer, is typically managed through surgical resection, localized ablation, or transarterial chemoembolization (TACE) when diagnosed at an intermediate stage without severe cirrhosis. The standard of care requires multidisciplinary intervention involving specialized hepato-pancreato-biliary surgeons and interventional radiologists.

The oncologist looked at the file and delivered the verdict:

"The tumor is localized, but our surgical schedule is currently full."

The most terrifying word in the consultation room was not cancer, but a question:

When?

Demand for specialized interventional oncology in the Gulf region frequently outpaces available operating theater capacity, with routine non-emergency surgical waitlists extending between six and twelve months in some public tertiary networks.

But Majed Al-Shehri doesn't experience the Saudi healthcare system as a national statistic.

He experiences it as a polite, apologetic receptionist handing him a card with a phone number.

He experiences it sitting in his car in the hospital parking lot, staring at the steering wheel.

He experiences it staring at his phone, waiting for a notification that does not come.

The assumption that patients seeking care abroad are merely impatient consumers is entirely false.

Majed Al-Shehri has followed every protocol.

He secured the initial referrals from his primary physician.

He waited six weeks for the diagnostic MRI.

He attended the multidisciplinary team consultation.

He inquired about private care at National Guard Hospital.

He researched best supportive care and palliative chemotherapy limits.

The internal framework changes:

From "Can I tolerate this?" to "How much of my life am I prepared to organise around it?"

There are premium private facilities in Riyadh and Jeddah.

They offer excellent, world-class oncological care.

But their specialized surgeons are often the same consultants working in the public sector.

The capacity constraint simply moves from a waitlist to a financial barrier, where out-of-pocket costs for private liver resection can rapidly deplete a lifetime of savings.

Majed Al-Shehri sits at his laptop at two in the morning.

He reads a forum post about an oncology center in Istanbul.

That instinct is entirely correct.

Price should never answer a medical question.

Istanbul has intentionally positioned itself as a high-capacity medical hub by integrating international accreditation standards with rapid treatment timelines.

But the country is not the deciding factor.

Countries do not perform partial hepatectomies.

Surgical teams do, clinical care units do, and interventional radiologists do.

There is a concrete, verifiable track record to examine in specific facilities.

Patients seeking cross-border care are strongly advised to verify independent clinical outcomes and coordinate with their domestic primary care network before committing to foreign intervention.

The indicative baseline cost for liver cancer surgery or complex transarterial chemoembolization in Istanbul varies between USD 15,000 and 25,000, depending heavily on tumor complexity, ICU requirements, and inpatient recovery duration.

His father used to say:

"What exactly am I getting?"

Twelve things the advertised price may or may not cover.

The advertised number is only the beginning of the conversation.

The list of questions sits on the dining table.

It is longer than the original diagnosis report.

Majed Al-Shehri realizes he is managing a complex project, not just an illness.

Surgical resection for hepatocellular carcinoma involves removing the tumor alongside a margin of healthy liver tissue, relying on the organ's unique capacity to regenerate, provided the underlying cirrhosis is not too severe. It requires advanced intraoperative imaging, specialized clamping techniques to manage severe bleeding, and immediate access to a high-dependency care unit.

This clinical reality immediately reframes the geographical challenge.

"How do I manage the logistics of recovery away from home?"

An operation of this magnitude requires a highly structured postoperative environment.

Official medical travel guidelines note that variable discharge protocols often dictate the true duration of your stay abroad, emphasizing that safe commercial air travel may not be permitted for several weeks post-surgery.

This variation itself is the lesson.

This constraint must be part of the plan before committing, not afterward.

"Wait. Does that mean I might be stuck in a hotel for a month?"

Possibly, depending on your liver function tests and drain removals.

This isn't tourism in the usual sense.

There are no guided tours or sightseeing itineraries on this trip.

There is only the hospital, the hotel room, and the space between them.

The reality is entirely clinical.

The invisible second participant carries an enormous operational load.

Amira will carry the passports, the physical medical files, and the medication schedule.

She will be the one trying to read a Turkish pharmacy receipt.

She will watch the monitor in the ICU waiting room.

She needs to know exactly who to call if Majed Al-Shehri's breathing changes.

Private health insurance coverage for elective international care typically requires explicit pre-authorization and often excludes companion logistical support unless specifically ridered.

She is part of the care system too.

Hepatic surgery carries intrinsic, undeniable physiological dangers.

Major risks include post-hepatectomy liver failure, biliary leakage, intra-abdominal bleeding, and deep vein thrombosis. The complexity of managing underlying cirrhosis alongside the malignancy complicates recovery immensely.

Majed Al-Shehri learns to immediately distrust certain phrases:

Informed consent means understanding more than the hoped-for outcome.

He no longer asks if the procedure is affordable or rapid.

They don't only want someone willing to do the operation.

They want someone willing not to.

The tone of the virtual consultations changes.

The foreign surgeons speak to him differently now.

He has become a partner in his own clinical strategy.

Saudi patients have a formalized right to seek secondary medical boards and apply for specialized treatment outside their primary healthcare cluster under state provisions if domestic care cannot be provided in a timely manner.

The comparison must be fair:

The dining table is covered in documents.

The translated radiology report from Riyadh.

The quoted surgical plan from the hospital in Istanbul.

The flight schedules to Sabiha Gökçen Airport.

The printed map showing the distance from the hotel to the clinic.

The research didn't make them more afraid; it made them more capable of deciding.

But what he actually wants is to schedule surgery in Istanbul within four weeks, complete treatment within three months, and return home cancer-free.

He wants to sit at his desk in the logistics firm without a dull ache in his side.

He wants to watch his daughter graduate next spring.

He wants his wife to sleep through the night without listening to his breathing.

But what he actually wants is a single objective:

You might realize the logistical burden on your spouse is too high.

You might secure a cancellation slot at King Majed Al-Shehri Specialist Hospital tomorrow.

You might discover the tumor has progressed and palliation at home is the wisest choice.

You might conclude the financial stretch is unjustified without guaranteed outcomes.

You might simply decide the comfort of your own bed outweighs the speed of an overseas clinic.

But choosing to fly, armed with hard questions and clear expectations, is also a valid path.

Any of those can be an informed decision.

Maybe you are sitting in a parked car holding an appointment card.

Maybe you are watching your spouse research clinics late at night.

Maybe you are staring at an abdominal scan you do not fully understand.

Maybe you are tired of being told to be patient.

Maybe you feel like the system has forgotten you.

You do not need to decide today.

The aim is not just to find different prices.

The aim is to find viable paths forward.

Hope is not the guarantee that surgery will be completely safe.

Hope is not the assurance that every trace of illness will be removed forever.

Hope is not a glossy brochure from a foreign hospital.

Hope is having enough accurate, unsentimental information to make a decision that feels like yours.

It is knowing what questions to ask.

It is understanding the risks and accepting them clearly.

It is reclaiming agency over a body that feels like it is failing.

It is looking at a problem and seeing a mechanism to address it.

He finally changes his perspective: